Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
stomatognathic diseases | D009057 |
eye diseases | D005128 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OCUSERT PILO-20 | Epic Pharma | N-017431 DISCN | 1982-01-01 | 1 products |
OCUSERT PILO-40 | Epic Pharma | N-017548 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BETOPTIC PILO | Alcon Research | N-020619 DISCN | 1997-04-17 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
betoptic pilo | 2006-06-19 | |
pilocarpine | unapproved drug other | 2011-12-02 |
pilocarpine hydrchloride | ANDA | 2024-05-31 |
pilocarpine hydrochloride | NDA authorized generic | 2025-01-07 |
qlosi | New Drug Application | 2024-06-24 |
salagen | New Drug Application | 2024-12-05 |
vuity | New Drug Application | 2023-03-28 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
head and neck neoplasms | — | D006258 | — |
xerostomia | — | D014987 | K11.7 |
angle-closure glaucoma | — | D015812 | — |
mydriasis | — | D015878 | H57.04 |
hypertension | EFO_0000537 | D006973 | I10 |
open-angle glaucoma | EFO_0004190 | D005902 | H40.1 |
Expiration | Code | ||
---|---|---|---|
PILOCARPINE HYDROCHLORIDE, VUITY, ABBVIE | |||
2026-03-28 | D-187 | ||
2024-10-28 | NP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glaucoma | D005901 | EFO_0000516 | H40 | — | — | — | 1 | — | 1 |
Angle-closure glaucoma | D015812 | — | — | — | — | — | 1 | — | 1 |
Drug common name | Pilocarpine |
INN | — |
Description | (+)-pilocarpine is the (+)-enantiomer of pilocarpine. It has a role as an antiglaucoma drug. It is an enantiomer of a (-)-pilocarpine. |
Classification | Small molecule |
Drug class | tricyclic compounds |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C |